Gender differences in changes in metabolic syndrome status and its components and risk of cardiovascular disease: a longitudinal cohort study

Cornier M-A, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, et al. The metabolic syndrome. Endocr Rev. 2008;29(7):777–822.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wilson PW, D’Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005;112(20):3066–72.

Article  CAS  PubMed  Google Scholar 

Shin JA, Lee JH, Lim SY, Ha HS, Kwon HS, Park YM, et al. Metabolic syndrome as a predictor of type 2 diabetes, and its clinical interpretations and usefulness. J diabetes Invest. 2013;4(4):334–43.

Article  CAS  Google Scholar 

Malik S, Wong ND, Franklin SS, Kamath TV, L’Italien GJ, Pio JR, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 2004;110(10):1245–50.

Article  PubMed  Google Scholar 

Khashayar P, Heshmat R, Qorbani M, Motlagh ME, Aminaee T, Ardalan G, et al. Metabolic syndrome and cardiovascular risk factors in a national sample of adolescent population in the middle east and north Africa: the CASPIAN III study. International journal of endocrinology. 2013;2013.

Ramezankhani A, Azizi F, Hadaegh F, Eskandari F. Sex-specific clustering of metabolic risk factors and their association with incident cardiovascular diseases: a population-based prospective study. Atherosclerosis. 2017;263:249–56.

Article  CAS  PubMed  Google Scholar 

Guembe MJ, Fernandez-Lazaro CI, Sayon-Orea C, Toledo E, Moreno-Iribas C. Risk for cardiovascular disease associated with metabolic syndrome and its components: a 13-year prospective study in the RIVANA cohort. Cardiovasc Diabetol. 2020;19(1):1–14.

Article  Google Scholar 

Ramezankhani A, Azizi F, Hadaegh F. Sex-specific clustering of metabolic risk factors and cancer risk: a longitudinal study in Iran. Biology of Sex Differences. 2020;11(1):21.

Article  PubMed  PubMed Central  Google Scholar 

Uzunlulu M, Caklili OT, Oguz A. Association between metabolic syndrome and cancer. Annals of Nutrition and Metabolism. 2016;68(3):173–9.

Article  CAS  PubMed  Google Scholar 

O’Neill S, O’Driscoll L. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes Rev. 2015;16(1):1–12.

Article  PubMed  Google Scholar 

Collaborators GO. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377(1):13–27.

Article  Google Scholar 

Kaur J. A comprehensive review on metabolic syndrome. Cardiology research and practice. 2014;2014.

Noubiap JJ, Nansseu JR, Lontchi-Yimagou E, Nkeck JR, Nyaga UF, Ngouo AT, et al. Geographic distribution of metabolic syndrome and its components in the general adult population: a meta-analysis of global data from 28 million individuals. Diabetes Res Clin Pract. 2022;188:109924.

Article  CAS  PubMed  Google Scholar 

Tabatabaei-Malazy O, Saeedi Moghaddam S, Rezaei N, Sheidaei A, Hajipour MJ, Mahmoudi N, et al. A nationwide study of metabolic syndrome prevalence in Iran; a comparative analysis of six definitions. PLoS ONE. 2021;16(3):e0241926.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hadaegh F, Hasheminia M, Lotfaliany M, Mohebi R, Azizi F, Tohidi M. Incidence of metabolic syndrome over 9 years follow-up; the importance of sex differences in the role of insulin resistance and other risk factors. PLoS ONE. 2013;8(9):e76304.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol. 2007;49(4):403–14.

Article  CAS  PubMed  Google Scholar 

Regensteiner JG, Reusch JE. Sex differences in cardiovascular consequences of hypertension, obesity, and diabetes: JACC focus seminar 4/7. J Am Coll Cardiol. 2022;79(15):1492–505.

Article  PubMed  PubMed Central  Google Scholar 

Peters SA, Huxley RR, Woodward M. Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775,385 individuals and 12,539 strokes. Lancet (London England). 2014;383(9933):1973–80.

Article  Google Scholar 

Noursi S, Clayton JA. Developing the process and tracking the implementation and evaluation of the national institutes of health strategic plan for women’s health research. Global Adv Health Med. 2021;10:21649561211042583.

Article  Google Scholar 

Hulthe J, Bokemark L, Wikstrand J, Fagerberg B. The metabolic syndrome, LDL particle size, and atherosclerosis: the Atherosclerosis and Insulin Resistance (AIR) study. Arteriosclerosis, thrombosis, and vascular biology. 2000;20(9):2140–7.

Kip KE, Marroquin OC, Kelley DE, Johnson BD, Kelsey SF, Shaw LJ, et al. Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women’s Ischemia Syndrome Evaluation (WISE) study. Circulation. 2004;109(6):706–13.

Article  PubMed  Google Scholar 

Lakka H-M, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288(21):2709–16.

Article  PubMed  Google Scholar 

Zabetian A, Hadaegh F, Azizi F. Relationship between metabolic syndrome and its components with coronary heart disease in Iranian men and women. Exp Clin Endocrinol Diabetes. 2008;116(09):525–31.

Article  CAS  PubMed  Google Scholar 

Hadaegh F, Shafiee G, Ghasemi A, Sarbakhsh P, Azizi F. Impact of metabolic syndrome, diabetes and prediabetes on cardiovascular events: Tehran lipid and glucose study. Diabetes Res Clin Pract. 2010;87(3):342–7.

Article  CAS  PubMed  Google Scholar 

Park S, Lee S, Kim Y, Lee Y, Kang MW, Han K, et al. Altered risk for cardiovascular events with changes in the metabolic syndrome status: a nationwide population-based study of approximately 10 million persons. Ann Intern Med. 2019;171(12):875–84.

Article  PubMed  Google Scholar 

He D, Zhang X, Chen S, Dai C, Wu Q, Zhou Y, et al. Dynamic Changes of Metabolic Syndrome Alter the Risks of Cardiovascular Diseases and All-Cause Mortality: Evidence From a Prospective Cohort Study. Frontiers in cardiovascular medicine. 2021:860.

Jaacks LM, Vandevijvere S, Pan A, McGowan CJ, Wallace C, Imamura F, et al. The obesity transition: stages of the global epidemic. The lancet Diabetes & endocrinology. 2019;7(3):231–40.

Article  Google Scholar 

Mensah GA, Fuster V. Sex and Gender Differences in Cardiovascular Health. Am Coll Cardiol. 2022;79(14):1385–7.

Article  Google Scholar 

Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, Hedayati M, et al. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials. 2009;10(1):1–15.

Article  Google Scholar 

Azizi F, Rahmani M, Emami H, Mirmiran P, Hajipour R, Madjid M, et al. Cardiovascular risk factors in an Iranian urban population: Tehran lipid and glucose study (phase 1). Sozial-und präventivmedizin. 2002;47(6):408–26.

Article  PubMed  Google Scholar 

Khalili D, Azizi F, Asgari S, Zadeh-Vakili A, Momenan AA, Ghanbarian A, et al. Outcomes of a longitudinal population-based cohort study and pragmatic community trial: findings from 20 years of the Tehran Lipid and Glucose Study. International journal of endocrinology and metabolism. 2018;16(4 Suppl).

Jeon CY, Lokken RP, Hu FB, Van Dam RM. Physical activity of moderate intensity and risk of type 2 diabetes: a systematic review. Diabetes Care. 2007;30(3):744–52.

Article  PubMed  Google Scholar 

Momenan AA, Delshad M, Sarbazi N, Rezaei_Ghaleh N, Ghanbarian A, Azizi F. Reliability and validity of the Modifiable Activity Questionnaire (MAQ) in an Iranian urban adult population. Arch Iran Med. 2012;15(5):279–82.

PubMed  Google Scholar 

Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation. 2009;120(16):1640–5.

Article  CAS  PubMed  Google Scholar 

Azizi F, Khalili D, Aghajani H, Esteghamati A, Hosseinpanah F, Delavari A, et al. Appropriate waist circumference cut-off points among Iranian adults: the first report of the Iranian National Committee of Obesity. Arch Iran Med. 2010;13(3):243–4.

PubMed  Google Scholar 

Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med. 2006;119(10):812–9.

Article  CAS  PubMed  Google Scholar 

Regitz-Zagrosek V, Lehmkuhl E, Mahmoodzadeh S. Gender aspects of the role of the metabolic syndrome as a risk factor for cardiovascular disease. Gend Med. 2007;4:162-S77.

Article  Google Scholar 

Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, et al. The metabolic syndrome and cardiovascular risk: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;56(14):1113–32.

Article  PubMed  Google Scholar 

Peters SA, Bots SH, Woodward M. Sex differences in the association between measures of general and central adiposity and the risk of myocardial infarction: results from the UK Biobank. J Am Heart Association. 2018;7(5):e008507.

Article  Google Scholar 

Suh S, Baek J, Bae JC, Kim K-N, Park MK, Kim DK, et al. Sex factors in the metabolic syndrome as a predictor of cardiovascular disease. Endocrinol metabolism. 2014;29(4):522–9.

Article  Google Scholar 

Yu S, Guo X, Li G, Yang H, Zheng L, Sun Y. Gender discrepancy in the predictive effect of metabolic syndrome and its components on newly onset cardiovascular disease in elderly from rural China. BMC Geriatr. 2021;21(1):1–10.

Article  CAS  Google Scholar 

Pinkerton JV. Hormone therapy for postmenopausal women. N Engl J Med. 2020;382(5):446–55.

Article  PubMed  Google Scholar 

Nappi RE, Simoncini T. Menopause transition: A golden age to prevent cardiovascular disease. The Lancet Diabetes & Endocrinology. 2021;9(3):135–7.

Article  Google Scholar 

Ramezankhani A, Azizi F, Momenan AA, Hadaegh F. Sex differences in cumulative exposure to

留言 (0)

沒有登入
gif